Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRAUER & WEIL vs TATVA CHINTAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRAUER & WEIL TATVA CHINTAN PHARMA GRAUER & WEIL/
TATVA CHINTAN PHARMA
 
P/E (TTM) x 28.9 107.2 27.0% View Chart
P/BV x 5.8 2.6 224.6% View Chart
Dividend Yield % 0.5 0.2 197.5%  

Financials

 GRAUER & WEIL   TATVA CHINTAN PHARMA
EQUITY SHARE DATA
    GRAUER & WEIL
Mar-24
TATVA CHINTAN PHARMA
Mar-24
GRAUER & WEIL/
TATVA CHINTAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1021,888 5.4%   
Low Rs491,063 4.6%   
Sales per share (Unadj.) Rs47.1168.2 28.0%  
Earnings per share (Unadj.) Rs6.513.0 49.7%  
Cash flow per share (Unadj.) Rs7.423.9 30.9%  
Dividends per share (Unadj.) Rs0.502.00 25.0%  
Avg Dividend yield %0.70.1 487.4%  
Book value per share (Unadj.) Rs35.5315.1 11.3%  
Shares outstanding (eoy) m226.7123.39 969.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.68.8 18.3%   
Avg P/E ratio x11.7113.7 10.3%  
P/CF ratio (eoy) x10.361.7 16.6%  
Price / Book Value ratio x2.14.7 45.5%  
Dividend payout %7.715.4 50.3%   
Avg Mkt Cap Rs m17,16234,520 49.7%   
No. of employees `000NANA-   
Total wages/salary Rs m1,066548 194.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,6893,935 271.6%  
Other income Rs m33575 446.4%   
Total revenues Rs m11,0244,010 274.9%   
Gross profit Rs m1,886684 275.7%  
Depreciation Rs m211256 82.5%   
Interest Rs m4867 70.9%   
Profit before tax Rs m1,962436 450.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m499132 378.0%   
Profit after tax Rs m1,463304 481.9%  
Gross profit margin %17.617.4 101.5%  
Effective tax rate %25.530.3 83.9%   
Net profit margin %13.77.7 177.4%  
BALANCE SHEET DATA
Current assets Rs m8,3353,052 273.1%   
Current liabilities Rs m2,636870 302.9%   
Net working cap to sales %53.355.5 96.1%  
Current ratio x3.23.5 90.1%  
Inventory Days Days2814 200.4%  
Debtors Days Days63465 979.0%  
Net fixed assets Rs m2,9185,085 57.4%   
Share capital Rs m227234 96.9%   
"Free" reserves Rs m7,8257,137 109.6%   
Net worth Rs m8,0527,371 109.2%   
Long term debt Rs m306 470.3%   
Total assets Rs m11,2538,138 138.3%  
Interest coverage x42.17.5 563.9%   
Debt to equity ratio x00 430.5%  
Sales to assets ratio x0.90.5 196.4%   
Return on assets %13.44.6 294.6%  
Return on equity %18.24.1 441.1%  
Return on capital %24.96.8 364.8%  
Exports to sales %5.473.1 7.4%   
Imports to sales %9.018.3 48.8%   
Exports (fob) Rs m5752,876 20.0%   
Imports (cif) Rs m957722 132.5%   
Fx inflow Rs m5752,876 20.0%   
Fx outflow Rs m987722 136.6%   
Net fx Rs m-4112,154 -19.1%   
CASH FLOW
From Operations Rs m1,591980 162.3%  
From Investments Rs m-1,082-1,205 89.7%  
From Financial Activity Rs m-202305 -66.3%  
Net Cashflow Rs m30779 386.6%  

Share Holding

Indian Promoters % 69.0 72.0 95.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 10.2 9.8%  
FIIs % 1.0 3.3 28.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.0 28.0 110.7%  
Shareholders   60,540 79,623 76.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRAUER & WEIL With:   PIDILITE INDUSTRIES    SRF    BALAJI AMINES    YASHO INDUSTRIES    NAVIN FLUORINE    


More on GRAUER & WEIL vs TATVA CHINTAN PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GRAUER & WEIL vs TATVA CHINTAN PHARMA Share Price Performance

Period GRAUER & WEIL TATVA CHINTAN PHARMA
1-Day -0.10% -2.70%
1-Month -12.84% -16.54%
1-Year 70.83% -45.71%
3-Year CAGR 49.11% -32.12%
5-Year CAGR 33.58% -18.97%

* Compound Annual Growth Rate

Here are more details on the GRAUER & WEIL share price and the TATVA CHINTAN PHARMA share price.

Moving on to shareholding structures...

The promoters of GRAUER & WEIL hold a 69.0% stake in the company. In case of TATVA CHINTAN PHARMA the stake stands at 72.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GRAUER & WEIL and the shareholding pattern of TATVA CHINTAN PHARMA.

Finally, a word on dividends...

In the most recent financial year, GRAUER & WEIL paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 7.7%.

TATVA CHINTAN PHARMA paid Rs 2.0, and its dividend payout ratio stood at 15.4%.

You may visit here to review the dividend history of GRAUER & WEIL, and the dividend history of TATVA CHINTAN PHARMA.



Today's Market

Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.